Antitrust authorities have raised concerns that digital marketplaces favor themselves and their products relative to how they treat other third-parties, a concept known as self-preferencing. The ...
PALO ALTO, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, ...
The rise of plant-based foods has reshaped the food industry, driving an increasing demand for alternatives to traditional animal-derived products. But formulating these products requires overcoming ...
Multi-label attribute recognition is a critical task in computer vision, with applications ranging across diverse fields. This problem often involves detecting objects with multiple attributes, ...
In the phase 3 randomized controlled study ATTRibute-CM (Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy), acoramidis, a transthyretin stabilizer, demonstrated ...
PALO ALTO, Calif., Oct. 03, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases, ...
- In participants who switched from tafamidis and placebo in the ATTRibute-CM study to acoramidis in its open-label extension (OLE), there was a mean of 3.0mg/dL increase in serum transthyretin (TTR) ...
According to the recent FMI report, the sales for pea starch is expected to surpass a value of US$ 115.9 Million in 2031, rising at a CAGR of around 5.2% through the end of 2031. Dried peas have been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback